Translational PsychiatryNeurosciencePeer-reviewed journal article
Protein expression of prenyltransferase subunits in postmortem schizophrenia dorsolateral prefrontal cortex
Anita L. PinneriD, Toni MuelleriD, Khaled AlganemiD, Robert Erne McCullumsmithiD, James H. Meador‐WoodruffiD
Abstract
The pathophysiology of schizophrenia includes altered neurotransmission, dysregulated intracellular signaling pathway activity, and abnormal dendritic morphology that contribute to deficits of synaptic plasticity in the disorder. These processes all require dynamic protein-protein interactions at cell membranes. Lipid modifications target proteins to membranes by increasing substrate hydrophobicity by the addition of a fatty acid or isoprenyl moiety, and recent evidence suggests that dysregulated post-translational lipid modifications may play a role in multiple neuropsychiatric disorders including schizophrenia. Consistent with these emerging findings, we have recently reported decreased protein S-palmitoylation in schizophrenia. Protein prenylation is a lipid modification that occurs upstream of S-palmitoylation on many protein substrates, facilitating membrane localization and activity of key intracellular signaling proteins. Accordingly, we hypothesized that in addition to palmitoylation, protein prenylation may be abnormal in schizophrenia. To test this, we assayed protein expression of the five prenyltransferase subunits (FNTA, FNTB, PGGT1B, RABGGTA, and RABGGTB) in postmortem dorsolateral prefrontal cortex from patients with schizophrenia and paired comparison subjects (N = 13 pairs). We found decreased levels of FNTA (14%), PGGT1B (13%), and RABGGTB (8%) in schizophrenia. To determine if upstream or downstream factors may be driving these changes, we also assayed protein expression of the isoprenoid synthases FDPS and GGPS1, and prenylation-dependent processing enzymes REC and ICMT. We found these upstream and downstream enzymes to have normal protein expression. To rule out effects from chronic antipsychotic treatment, we assayed FNTA, PGGT1B and RABGGTB in cortex from rats treated long-term with haloperidol decanoate, and found no change in the expression of these proteins. Given the role prenylation plays in localization of key signaling proteins found at the synapse, these data offer a potential mechanism underlying abnormal protein-protein interactions and protein localization in schizophrenia.
- Citations
- 16
- FWCI
- 1.64
- Field percentile
- top 19%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The mitochondrial matrix protein cyclophilin D contributes to deficits in parvalbumin interneurons in schizophrenia
John Tiernan O'Brien, Sophia P. Jalilvand, … Sven Kroener·bioRxiv·May 19, 2023
- Lipid-correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophrenia
W. Arihisa, T. Kondo, … M. Setou·bioRxiv·Mar 14, 2022
- Pharmacological impacts on schizophrenia functional analysis: a postmortem proteome study.
Rawan S. Alnafisah, James K. Reigle, … Rammohan Shukla·bioRxiv·Oct 26, 2021
- Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology.
Amira Ben Afia, Èlia Vila, … Borja García‐Bueno·Journal of NeuroinflammationPeer-reviewed·Sep 12, 2021
- Glycosylation enzyme mRNA expression in dorsolateral prefrontal cortex of elderly patients with schizophrenia: Evidence for dysregulation of multiple glycosylation pathways
Toni Mueller, Micah S. Simmons, … James H. Meador‐Woodruff·bioRxiv·Jul 14, 2018
- CALCIUM-BINDING PROTEINS ARE ALTERED IN THE CEREBELLUM IN SCHIZOPHRENIA
Francisco Vidal-Domènech, Gemma Riquelme Alacid, … Belén Ramos·PLoS ONEPeer-reviewed·Jul 8, 2020